Federal Circuit clarifies patent-eligibility under 35 U.S.C. § 101 for claims covering recombinant DNA molecules

Federal Circuit clarifies the term “by another” in pre-AIA 35 U.S.C. §§ 102(a) and (e)

The Federal Circuit clarifies AIA derivation standards: Independent conception is key

Federal Circuit Limits the Application of Obviousness-Type Double Patenting for Patents in the Same Family

PTAB Dashboard

U.S. Patent and Trademark Office seeks stakeholder input on Patent Trial and Appeal Board decision-making procedures

Federal Circuit Potentially Widens Door for PTAB to Identify Its Own Unpatentability Grounds for Substitute Claims

Biogen rehearing denied: Is SCOTUS the next step?